Drug GSK5764227 for metastatic colorectal cancer (223675)

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
[223675] A Phase1b/2, multicenter, randomized, open-label study to evaluate the efficacy and safety of GSK5764227 alone and in combination in participants with previously treated advanced unresectable or metastatic gastrointestinal solid tumors
Principal Investigator
Headshot of Nicholas Christian DeVito
Assistant Professor of Medicine
Protocol Number
IRB: PRO00118141
NCT: NCT06885034
Phase
Phase I/II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate